BAX Baxter International Inc

Price (delayed)

$66.78

Market cap

$33.63B

P/E Ratio

31.65

Dividend/share

$1.13

EPS

$2.11

Enterprise value

$49.01B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
BAX's P/E is 18% below its 5-year quarterly average of 38.6 and 9% below its last 4 quarters average of 34.9
The gross profit has grown by 16% year-on-year and by 4% since the previous quarter
Baxter International's debt has soared by 170% YoY but it has decreased by 2.7% from the previous quarter
The quick ratio is down by 24% year-on-year and by 8% since the previous quarter
BAX's net income is down by 18% since the previous quarter

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
503.53M
Market cap
$33.63B
Enterprise value
$49.01B
Valuations
Price to earnings (P/E)
31.65
Price to book (P/B)
3.7
Price to sales (P/S)
2.48
EV/EBIT
33.76
EV/EBITDA
19.57
EV/Sales
3.62
Earnings
Revenue
$13.55B
EBIT
$1.45B
EBITDA
$2.51B
Free cash flow
$1.34B
Per share
EPS
$2.11
Free cash flow per share
$2.67
Book value per share
$18.07
Revenue per share
$26.93
TBVPS
$30.23
Balance sheet
Total assets
$32.72B
Total liabilities
$23.6B
Debt
$17.68B
Equity
$9.08B
Working capital
$4.28B
Liquidity
Debt to equity
1.95
Current ratio
2.1
Quick ratio
1.22
Net debt/EBITDA
6.14
Margins
EBITDA margin
18.5%
Gross margin
39.2%
Net margin
7.8%
Operating margin
10.9%
Efficiency
Return on assets
4%
Return on equity
11.9%
Return on invested capital
7%
Return on capital employed
5%
Return on sales
10.7%
Dividend
Dividend yield
1.69%
DPS
$1.13
Payout ratio
53.6%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
2.61%
1 week
4.62%
1 month
-9.63%
1 year
-17.96%
YTD
-22.2%
QTD
-13.88%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$13.55B
Gross profit
$5.31B
Operating income
$1.48B
Net income
$1.06B
Gross margin
39.2%
Net margin
7.8%
Baxter International's net margin has decreased by 22% from the previous quarter and by 13% YoY
The operating margin has decreased by 19% YoY and by 19% from the previous quarter
BAX's net income is down by 18% since the previous quarter
The gross profit has grown by 16% year-on-year and by 4% since the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
31.65
P/B
3.7
P/S
2.48
EV/EBIT
33.76
EV/EBITDA
19.57
EV/Sales
3.62
BAX's P/E is 18% below its 5-year quarterly average of 38.6 and 9% below its last 4 quarters average of 34.9
The EPS has contracted by 18% from the previous quarter
BAX's P/B is 21% below its 5-year quarterly average of 4.7 and 20% below its last 4 quarters average of 4.6
The company's equity rose by 7% YoY
BAX's P/S is 29% below its 5-year quarterly average of 3.5 and 23% below its last 4 quarters average of 3.2
The revenue is up by 15% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Baxter International business performance
The ROA has contracted by 29% from the previous quarter and by 26% YoY
The ROIC has decreased by 27% YoY and by 26% from the previous quarter
The company's return on equity fell by 20% QoQ and by 6% YoY
The ROS has contracted by 18% from the previous quarter and by 10% YoY

Dividends

What is BAX's dividend history
DPS
$1.13
Dividend yield
1.69%
Payout ratio
53.6%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 39% more than the total liabilities
The total liabilities has soared by 115% YoY but it has decreased by 3.3% from the previous quarter
The total assets has soared by 68% YoY but it has contracted by 2.4% from the previous quarter
Baxter International's debt is 95% more than its equity
Baxter International's debt has soared by 170% YoY but it has decreased by 2.7% from the previous quarter
The debt to equity has surged by 150% year-on-year but it has declined by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.